Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

Abstract Background Mantle cell lymphoma (MCL) is a B cell malignancy that can be aggressive and with a poor prognosis; the clinical course is heterogeneous. The epidemiology of MCL in Asia is not well documented but appears to comprise 2–6% of all lymphoma cases based on available data, with variat...

Full description

Bibliographic Details
Main Authors: Dok Hyun Yoon, Junning Cao, Tsai-Yun Chen, Koji Izutsu, Seok Jin Kim, Yok Lam Kwong, Tong Yu Lin, Lim Soon Thye, Bing Xu, Deok Hwan Yang, Won Seog Kim
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Journal of Hematology & Oncology
Subjects:
Mantle cell lymphoma
Asia
Treatment
Guidelines
Online Access:http://link.springer.com/article/10.1186/s13045-020-00855-9

Internet

http://link.springer.com/article/10.1186/s13045-020-00855-9

Similar Items